Circular by Design
Seprify, founded by Lukas Schertel and Oliver Polcher, uses cellulose to create sustainable alternatives to TiO₂. The Cambridge spinout’s platform is backed by CTO Wadood Hamad’s expertise.
Interview with Lukas Schertel, Seprify

Co-founded by physicist Lukas Schertel and serial entrepreneur Oliver Polcher, Seprify transforms cellulose into high-performance functional ingredients inspired by nature’s light-scattering systems. Originating from research at the University of Cambridge, the Swiss start-up has developed a platform technology that enables sustainable alternatives to conventional ingredients such as titanium dioxide (TiO2). The leadership team is complemented by Chief Technology Officer Wadood Hamad, who brings extensive expertise in cellulose applications and processing.
CHEManager: Can you explain the core innovation in simple terms for our readers?
Lukas Schertel: Seprify engineers cellulose, the most abundant natural polymer, into microstructured particles that control how light interacts with a material. Instead of relying on chemical composition, we design the structure of cellulose at the micro-scale to achieve properties like whiteness, opacity, or SPF boosting.
Nature does this extremely well. For example, the Cyphochilus beetle (a core inspiration for our technology) appears intensely white not because of pigments, but because of how its microscopic structure scatters light. We replicate that same principle using cellulose. The result is a single, bio-based material that can deliver multiple functions across a range of industries from personal care and cosmetics to food, pet food, nutraceuticals and coatings.
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
most read

Relocation of Chemicals Production Footprint in Full Swing
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.







